Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

MERCK KGAA : Credit Suisse gives a Buy rating

09/17/2020 | 02:13am EDT

Analyst Trung Huynh from Credit Suisse research considers the stock attractive and recommends it with a Buy rating. The target price has been lifted and is now set at EUR 140 compared to EUR 125 before.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
CREDIT SUISSE GROUP AG -0.04% 9.404 Delayed Quote.-17.47%
MERCK KGAA 1.09% 153.65 Delayed Quote.8.30%
All news about MERCK KGAA
06/15MERCK KGAA  : Berenberg gives a Neutral rating
MD
06/10Volkswagen, Nine Others Set Up Quantum Technology & Application Consortium
MT
06/10MERCK  : Obtains Halal Certifications For All Cosmetics Products
MT
06/10PRESS RELEASE : ObsEva Presents PROLONG Phase 2a Proof-of-Concept Data on Ebopip..
DJ
06/09MERCK KGAA  : UBS reaffirms its Neutral rating
MD
06/02Germany to build up reserve vaccine capacity to fight future pandemics
RE
06/02PRESS RELEASE : CureVac Appoints Klaus Edvardsen as Chief Development Officer
DJ
06/01Immutep, Merck KGaA Expand Collaboration in Solid Tumors
MT
06/01Merck KgaA Partners With Immutep For Trial In Solid Tumor Patients
MT
06/01Immutep in Collaboration, Supply Agreement With Merck KGaA
DJ
More news
Financials
Sales 2021 18 882 M 22 495 M 22 495 M
Net income 2021 2 551 M 3 039 M 3 039 M
Net Debt 2021 8 694 M 10 358 M 10 358 M
P/E ratio 2021 25,6x
Yield 2021 1,00%
Capitalization 66 804 M 79 585 M 79 588 M
EV / Sales 2021 4,00x
EV / Sales 2022 3,69x
Nbr of Employees 57 850
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 151,31 €
Last Close Price 152,00 €
Spread / Highest target 21,7%
Spread / Average Target -0,45%
Spread / Lowest Target -26,3%
EPS Revisions
Managers and Directors
NameTitle
Belén Garijo López Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Nilesh Kumar Senior Investment Director
Christian Raabe Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA8.30%78 348
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD51.39%37 864
KYOWA KIRIN CO., LTD.34.33%18 416
SK BIOPHARMACEUTICALS CO., LTD.-24.56%8 790
BETTA PHARMACEUTICALS CO., LTD.-5.48%6 526
YUHAN CORPORATION-14.78%3 683